Pharmaceutical Interventions for Emotionalism After Stroke
Stroke 54:e213-e214, Hackett,M.L.,et al, 2023
Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Monoamine Oxidase Inhibitors
Adams & Victors Principles of Neurology Chp 43, pg 1210, Ropper, A.H.,et al, 2014
Pharmaceutical Interventions for Emotionalism After Stroke
Stroke 41:e460-e461, Hackett,M.L., et al, 2010
Pharmacological treatment of Neuropsychiatric Symptoms of Dementia
JAMA 293:596-608, Sink,K.M.,et al, 2005
Pharmaceutical Interventions for Emotionalism After Stroke
Stroke 35:2610-2611, Horrocks,J.A.,et al, 2004
Ten Most Commonly Asked Questions About the Psychiatric Aspects of Parkinson's Disease
The Neurologist 9:50-56, Reich,S.G. & Marsh,L., 2003
Management of Chronic Tension-Type Headache with Tricyclic Antidepressant Medication, Stress Management Therapy, and Their Combination
JAMA 285:2208-2215, Holroyd,K.A.,et al, 2001
Managing the Neuropsychiatric Symptoms of Parkinson's Disease
Neurol 50:S33-S38, Lieberman,A., 1998
Clinical Features and Pharmacologic Treatment of Behavioral Symptoms of Alzheimer's Disease
Neurol 48 (Suppl 6) :S17-S24997., Borson,S.&Raskind,M.A., 1997
A Guide to Understanding & Use of Tricyclic Antidepress in Manage of Fibromyalgia & Other Chronic Pain Syndr
Arch Int Med 156:1047-1052, Godfrey,R.G., 1996
Management of the Behavioral Manifestations of Dementia
Arch Int Med 155:250-260, Yeager,B.F.,et al, 1995
Attention-Deficit Hyperactivity Disorder in Adults
Clinical Therapeutics 14:138-147, Bellak,L.&Black,R.B., 1992
Chronic Pain, A Management Plan Based on Experiences in a Pain Clinic
Postgrad Med 66:147-154, Gorsky,B.H., 1979